This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its India medical diagnostic service business to...
Drug use by the U.S. workforce increased each year -- and by double-digits over two years -- between 2015 and 2017, in five of 16 major U.S. industry sectors analyzed, according to a first-ever...
HARTFORD, Conn. & ST. LOUIS (Dec. 3, 2018) – Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce...
Nearly 80 percent of hospital executives surveyed are not at all familiar, or only somewhat familiar, with the Protecting Access to Medicare Act (PAMA) and its impact on hospitals, according to a...
At a meeting with analysts and investors at its Investor Day tomorrow, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will build a flagship laboratory in Clifton, N.J. to enhance...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to acquire the assets of the clinical...
CHICAGO, Nov.11, 2018 — Developing novel approaches to understand pre-disease and health is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of three studies at the 2018 American Heart Association...